245 related articles for article (PubMed ID: 33193737)
41. Mining Prognostic Biomarkers of Hepatocellular Carcinoma Based on Immune-Associated Genes.
Chen W; Tang D; Ou M; Dai Y
DNA Cell Biol; 2020 Apr; 39(4):499-512. PubMed ID: 32069130
[TBL] [Abstract][Full Text] [Related]
42. Overexpression of Karyopherin Subunit alpha 2 (KPNA2) Predicts Unfavorable Prognosis and Promotes Bladder Cancer Tumorigenicity via the P53 Pathway.
Shi C; Sun L; Liu S; Zhang E; Song Y
Med Sci Monit; 2020 Mar; 26():e921087. PubMed ID: 32147666
[TBL] [Abstract][Full Text] [Related]
43. TMEM205 Is an Independent Prognostic Factor and Is Associated With Immune Cell Infiltrates in Hepatocellular Carcinoma.
Rao J; Wu X; Zhou X; Deng R; Ma Y
Front Genet; 2020; 11():575776. PubMed ID: 33193690
[TBL] [Abstract][Full Text] [Related]
44. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
[TBL] [Abstract][Full Text] [Related]
45. Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma.
Dietrich P; Gaza A; Wormser L; Fritz V; Hellerbrand C; Bosserhoff AK
Neoplasia; 2019 Mar; 21(3):257-268. PubMed ID: 30685691
[TBL] [Abstract][Full Text] [Related]
46. CCNB2, NUSAP1 and TK1 are associated with the prognosis and progression of hepatocellular carcinoma, as revealed by co-expression analysis.
Liu L; Chen A; Chen S; Song W; Yao Q; Wang P; Zhou S
Exp Ther Med; 2020 Apr; 19(4):2679-2689. PubMed ID: 32256749
[TBL] [Abstract][Full Text] [Related]
47. Identification and validation of a ten-gene set variation score as a diagnostic and prognostic stratification tool in hepatocellular carcinoma.
Zou C; Yuan C; Ye J; Liu Z; Gao X; Piao X; Mai R; Lin Y; Zou D; Fang Z; Liang R
Am J Transl Res; 2020; 12(9):5683-5695. PubMed ID: 33042448
[TBL] [Abstract][Full Text] [Related]
48. Increased expression of KPNA2 predicts unfavorable prognosis in ovarian cancer patients, possibly by targeting KIF4A signaling.
Cui X; Wang H; Wu X; Huo K; Jing X
J Ovarian Res; 2021 May; 14(1):71. PubMed ID: 34034774
[TBL] [Abstract][Full Text] [Related]
49. Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets.
Zhou Y; Yin Z; Hou B; Yu M; Chen R; Jin H; Jian Z
Cancer Manag Res; 2019; 11():3921-3931. PubMed ID: 31118805
[No Abstract] [Full Text] [Related]
50. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.
Li GX; Ding ZY; Wang YW; Liu TT; Chen WX; Wu JJ; Xu WQ; Zhu P; Zhang BX
J Cell Physiol; 2019 Jul; 234(7):11942-11950. PubMed ID: 30536816
[TBL] [Abstract][Full Text] [Related]
51. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
Lu M; Kong X; Wang H; Huang G; Ye C; He Z
Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
[TBL] [Abstract][Full Text] [Related]
52. Construction of a 13-microRNA-based signature and prognostic nomogram for predicting overall survival in patients with hepatocellular carcinoma.
Zheng Z; Wen Y; Nie K; Tang S; Chen X; Lan S; Pan J; Jiang K; Jiang X; Liu P; Yan Y; Liu F; Liu Y; Li P
Hepatol Res; 2020 Oct; 50(10):1151-1163. PubMed ID: 32567216
[TBL] [Abstract][Full Text] [Related]
53. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
[TBL] [Abstract][Full Text] [Related]
54. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
55. Prognostic and immune regulating roles of YIF1B in Pan-Cancer: a potential target for both survival and therapy response evaluation.
Liu J; Chen Z; Zhao P; Li W
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32648580
[TBL] [Abstract][Full Text] [Related]
56. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
57. Oncogenic role of karyopherin α2 (KPNA2) in human tumors: A pan-cancer analysis.
Sun Y; Li W; Li X; Zheng H; Qiu Y; Yang H
Comput Biol Med; 2021 Dec; 139():104955. PubMed ID: 34735944
[TBL] [Abstract][Full Text] [Related]
58. Identification of Crucial Genes Associated With Immune Cell Infiltration in Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis.
Wang D; Liu J; Liu S; Li W
Front Genet; 2020; 11():342. PubMed ID: 32391055
[TBL] [Abstract][Full Text] [Related]
59. LncRNA NEAT1 Promotes Deterioration of Hepatocellular Carcinoma Based on In Vitro Experiments, Data Mining, and RT-qPCR Analysis.
Ling ZA; Xiong DD; Meng RM; Cen JM; Zhao N; Chen G; Li RL; Dang YW
Cell Physiol Biochem; 2018; 48(2):540-555. PubMed ID: 30021196
[TBL] [Abstract][Full Text] [Related]
60. Nuclear karyopherin alpha2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity.
Gluz O; Wild P; Meiler R; Diallo-Danebrock R; Ting E; Mohrmann S; Schuett G; Dahl E; Fuchs T; Herr A; Gaumann A; Frick M; Poremba C; Nitz UA; Hartmann A
Int J Cancer; 2008 Sep; 123(6):1433-8. PubMed ID: 18561322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]